专利检索 ap:("INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY" OR "KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY") AND inv:"Kyoung Oh CHO" 第 1 页

1.

发明公开
PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR FOR TREATMENT OR TREATMENT OF RNA VIRAL INFECTIONS 审中-公开

公开(公告)号：US20240285557A1

公开(公告)日：2024-08-29

申请号：US18572480

申请日：2022-06-24

申请人： INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY , KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY

发明人： Kyoung Oh CHO , Tae ll JEON , Sun Woo LEE , Yeong Bin BAEK , Hyung Jun Kwon , Hueng Sik CHOI , Sang lk PARK , Muhammad SHARIF , Jeong Ah LIM

IPC分类号： A61K31/17 , A61K31/215 , A61K31/675 , A61P31/14 , A61P31/16

CPC分类号： A61K31/17 , A61K31/215 , A61K31/675 , A61P31/14 , A61P31/16

摘要： The present invention relates to a therapeutic agent of a lipase inhibitor for a wide spectrum of RNA viral infections in humans and animals. More specifically, the lipase inhibitor can be used as a therapeutic agent for influenza A virus infection, bovine coronavirus infection, porcine epidemic diarrhea coronavirus infection, bovine rotavirus infection, porcine reproductive and respiratory syndrome virus infection, and sapoviral infection and furthermore, can be utilized as a therapeutic agent for various RNA viral infections in humans and animals, such as infections with SARS COV-1, MERS-COV, Zika virus, dengue fever virus, and hepatitis A and C viruses.